Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention
查看参考文献35篇
文摘
|
Background: Females with ST-segment elevation myocardial infarction (STEMI) have higher in-hospital and short-term mortality rates compared with males in China, suggesting that a sex disparity exists. The age of onset of STEMI is ahead of time and tends to be younger. However, there are relatively little data on the significance of sex on prognosis for long-term outcomes for adult patients with STEMI after percutaneous coronary intervention (PCI) in China. This study sought to analyze the sex differences in 30-day, 1-year, and long-term net adverse clinical events (NACEs) in Chinese adult patients with STEMI after PCI. Methods: This study retrospectively analyzed 1920 consecutive STEMI patients (age <60 years) treated with PCI from January 01, 2006, to December 31,2012. A propensity score analysis between males and females was performed to adjust for differences in baseline characteristics and comorbidities. The primary endpoint was the incidence of 3-year NACE. Survival curves were constructed with Kaplan-Meier estimates and compared by log-rank tests between the two groups. Multivariate analysis was performed using a Cox proportional hazards model for 3-year NACE. Results: Compared with males, females had higher risk profiles associated with old age, longer prehospital delay at the onset of STEMI, hypertension, diabetes mellitus, and chronic kidney disease, and a higher Killip class (≥3), with more multivessel diseases (P < 0.05). The female group had a higher levels of low-density lipoprotein (2.72 [2.27, 3.29] vs. 2.53 [2.12, 3.00], P < 0.001),high-density lipoprotein (1.43 [1.23, 1.71] vs. 1.36 [1.11,1.63],P=0.003),total cholesterol (4.98 ± 1.10 vs. 4.70 ± 1.15,t = -3.508,P< 0.001),and estimated glomerular filtration rate (103.12 ± 22.22 vs. 87.55 ± 18.03,t=-11.834,P < 0.001) than the male group. In the propensity-matched analysis, being female was associated with a higher risk for 3-year NACE and major adverse cardiac or cerebral events compared with males. In the multivariate model, female gender (hazard ratio [HR]: 2.557, 95% confidence interval [CI]: 1.415-4.620, P = 0.002), hypertension (HR: 2.017,95% CI: 1.138-3.576, P= 0.016), and family history of coronary heart disease (HR: 2.256,95% CI: 1.115-4.566, P=0.024) were independent risk factors for NACE. The number of stents (HR: 0.625,95% CI: 0.437-0.894, P= 0.010) was independent protective factors of NACE. Conclusions: Females with STEMI undergoing PCI have a significantly higher risk for 3-year NACE compared with males in this population. Sex differences appear to be a risk factor and present diagnostic challenges for clinicians. |
来源
|
Chinese Medical Journal
,2018,131(12):1420-1429 【核心库】
|
DOI
|
10.4103/0366-6999.233965
|
关键词
|
Percutaneous Coronary Intervention
;
Prognosis
;
Sex
;
ST-Segment Elevation Myocardial Infarction
|
地址
|
Department of Cardiology, The General Hospital of Shenyang Military Region, Liaoning, Shenyang, 110016
|
语种
|
英文 |
文献类型
|
研究性论文 |
ISSN
|
0366-6999 |
学科
|
医药、卫生 |
文献收藏号
|
CSCD:6266041
|
参考文献 共
35
共2页
|
1.
Yeh R W. Population trends in the incidence and outcomes of acute myocardial infarction.
New England J Med,2010,362:2155-2165
|
CSCD被引
43
次
|
|
|
|
2.
Writing Group Members. Executive summary: Heart disease and stroke statistics-2016 update: A Report from the American Heart Association.
Circulation,2016,133:447-454
|
CSCD被引
18
次
|
|
|
|
3.
Kolte D. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States.
J Am Heart Assoc,2014,3:e000590
|
CSCD被引
10
次
|
|
|
|
4.
Khera S. Non-ST-elevation myocardial infarction in the United States: Contemporary trends in incidence, utilization of the early invasive strategy, and in-hospital outcomes.
J Am Heart Assoc,2014,3:pii: e000995
|
CSCD被引
2
次
|
|
|
|
5.
Li G X. Current Trends for ST-segment Elevation Myocardial Infarction during the Past 5 Years in Rural Areas of China's Liaoning Province: A Multicenter Study.
Chin Med J,2017,130:757-766
|
CSCD被引
3
次
|
|
|
|
6.
O'Gara P T. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation,2013,127:e362-e425
|
CSCD被引
77
次
|
|
|
|
7.
Kang S H. Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry).
Am J Cardiol,2012,109:787-793
|
CSCD被引
5
次
|
|
|
|
8.
. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D,Badano LP, Blomstrom-Lundqvist C, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
Eur Heart J,2012,33:2569-2619
|
CSCD被引
8
次
|
|
|
|
9.
Zhang Z. Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction.
Am J Cardiol,2012,109:1097-1103
|
CSCD被引
2
次
|
|
|
|
10.
Jneid H. Sex differences in medical care and early death after acute myocardial infarction.
Circulation,2008,118:2803-2810
|
CSCD被引
19
次
|
|
|
|
11.
Champney K P. The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction.
Heart,2009,95:895-899
|
CSCD被引
5
次
|
|
|
|
12.
Poulter N. Global risk of cardiovascular disease.
Heart,2003,89(Suppl 2):ii2-5
|
CSCD被引
6
次
|
|
|
|
13.
Zhang B. Prospective multi-center study of female patients with ST-elevation myocardial infarction in Liaoning province, China.
Chin Med J,2012,125:1915-1919
|
CSCD被引
3
次
|
|
|
|
14.
Cutlip D E. Clinical end points in coronary stent trials: A case for standardized definitions.
Circulation,2007,115:2344-2351
|
CSCD被引
170
次
|
|
|
|
15.
Zheng X. Age-specific gender differences in early mortality following ST-segment elevation myocardial infarction in China.
Heart,2015,101:349-355
|
CSCD被引
8
次
|
|
|
|
16.
Second Chinese Cardiac Study (CCS-2) Collaborative Group. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): A randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
J Cardiovasc Risk,2000,7:435-441
|
CSCD被引
6
次
|
|
|
|
17.
Chen Z M. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial.
Lancet,2005,366:1622-1632
|
CSCD被引
37
次
|
|
|
|
18.
Chandrasekhar J. Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study.
Catheter Cardiovasc Interv,2017,89:629-637
|
CSCD被引
1
次
|
|
|
|
19.
D'Onofrio G. Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: Results from the VIRGO study.
Circulation,2015,131:1324-1332
|
CSCD被引
1
次
|
|
|
|
20.
Mendelsohn M E. The protective effects of estrogen on the cardiovascular system.
N Engl J Med,1999,340:1801-1811
|
CSCD被引
41
次
|
|
|
|
|